Table 2 Intraoperative fluid management as well as perioperative blood consumption intraoperatively, postoperatively and overall
From: Goal-directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia
Fluid management and blood transfusion | CTRL group | GDT group | P value |
|---|---|---|---|
Intraoperative period | |||
Dobutamine, n (%) | 0 (0%) | 11 (55%) | 0.0003 |
Dobutamine dose, μg/kg/minute | n/a | 4 ± 1 | n.a. |
Mean Crystalloids (± SD), mL | 2,100 ± 361 | 3,358 ± 825 | < 0.0001 |
Mean Colloids (± SD), mL | 535 ± 86 | 2,079 ± 858 | < 0.0001 |
Mean Blood (± SD), mL | 0 | 595 ± 316 | 0.0003 |
Mean Total input (± SD), mL | 2,635 ± 346 | 6,032 ± 1,388 | < 0.0001 |
Median Urine output (IQR), mL | 300 (100 to 475) | 1225 (650 to 1375) | < 0.0001 |
Median Blood loss (IQR), mL | 900 (800 to 975) | 900 (750 to 1200) | n.s. |
Mean Fluid balance (± SD), mL | 1,403 ± 401 | 3565 ± 879 | < 0.0001 |
Perioperative blood transfusion requirements, mL | |||
Mean Intraoperative blood transfusion (± SD) | 0 | 565 ± 332 | 0.0003 |
Mean Postoperative blood transfusion (± SD) | 658 ± 302 | 198 ± 292 | 0.0004 |
Mean Total blood transfusion (± SD) | 658 ± 302 | 792 ± 480 | n/s |